Senior insider sale
Chief Financial Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$44.3K
13.76K shares
What this filing means
HALLADAY BENJAMIN plans to sell 13.76K shares of ESPERION THERAPEUTICS, INC. valued at approximately $44.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002427
Officer· Chief Financial Officer
Since Nov 2022
13.76K
Shares to sell
$44.3K
Approx. market value
6.42K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
6.42KTotal acquired6.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 6.42K | — |
| Total | 6.42K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.34K
Market value
$26.9K
12/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.42K
Market value
$17.4K
3/17/2026
Total
Units
13.76K
Value
$44.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 7.34K | $26.9K | — | Completed |
| Planned — Approximate Date | ||||
3/17/2026 | 6.42K | $17.4K | NASDAQ | Planned |
| Total | 13.76K | $44.3K | ||